Chemo-induced myelosuppression can affect patients’ ability to do daily tasks, and management varies by patient, treatment ...
The addition of navtemadlin to ruxolitinib for JAK inhibitor-naive patients with myelofibrosis with suboptimal response to ...
On this episode of Onc Nurse On Call, Kristin Daly, MSN, ANP-BC, AOCNP, discusses practical cancer care strategies in the age ...
Panelists discuss how the IMscin001 trial findings established subcutaneous atezolizumab noninferiority with comparable efficacy and safety to intravenous (IV) formulation while highlighting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback